Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Type 2 Diabetes Models: Phase 3 TRANSCEND-T2D-1 data demonstrated HbA1c reductions of 1.7-2.0% and mean weight loss of 36.6 lbs over 40 weeks
Timing Baseline Monitoring guidance is pathway-based and cautious because SLU-PP-332 has limited human monitoring data
Use the peptide interaction checker before stacking products, and see GHK-Cu microneedling for a procedure that amplifies both benefits and risks
If youre a provider: Customization begins with your clinical expertise
Check the product name, batch and document before relying on it.
Ten weeks of GHK-Cu
US$ 25.97
US$ 21.49
US$ 24.76
US$ 26.48
